| TIPS 和 PTVE 治疗肝硬化食管胃底静脉曲张破裂出血的临床效果比较 |
| |
| 引用本文： | 羊丹,张国梁 △,王凤梅 △,边芬,贾科峰. TIPS 和 PTVE 治疗肝硬化食管胃底静脉曲张破裂出血的临床效果比较[J]. 天津医药, 2016, 44(5): 529-534. DOI: 10.11958/20160136 |
| |
| 作者姓名： | 羊丹 张国梁 △ 王凤梅 △ 边芬 贾科峰 |
| |
| 作者单位： | 1天津医科大学一中心临床学院 （邮编 300192）， 2消化内科； 3天津市第三中心医院消化 （肝病） 科， 4放射科 |
| |
| 摘 要： | 摘要： 目的 探讨经颈静脉肝内门体分流术 （TIPS） 和经皮经肝胃冠状静脉栓塞术 （PTVE） 对肝硬化食管胃底静脉曲张破裂出血的疗效。方法 回顾性分析因肝硬化食管胃底静脉曲张破裂出血就诊并实施介入治疗的 61 例患者资料， 其中 PTVE 组 42 例， TIPS 组 19 例。比较 2 组治疗成功率、 再出血率、 曲张静脉缓解情况、 肝性脑病发生率、生存率及肝功能变化等。结果 2 组手术均成功， TIPS 组术后门静脉压力明显下降， PTVE 组的再出血率为 78.6%，高于 TIPS 组的 63.2%， PTVE 组术后食管胃底静脉曲张缓解的有效率为 50.0%， 明显低于 TIPS 组的 89.5%（均 P＜0.05）； PTVE 组和 TIPS 组肝性脑病发生率分别为 14.3%和 26.3%， 2 年累积生存率分别为 95.2%和 89.5%， 差异均无统计学意义； PTVE 组术后各时期肝功变化与术前差异无统计学意义； TIPS 组术后 1、 3 个月肝功能较术前及 PTVE术后同一时期下降， 术后 6、 12 个月肝功能变化与术前及 PTVE 术后同一时期相比差异无统计学意义。结论 TIPS治疗肝硬化食管胃底静脉曲张破裂出血手术安全， 再出血率低， 食管胃底静脉曲张好转快， 术后中远期对肝功能影响较小， 是一种理想的介入治疗方法。
|
| 关 键 词： | 门体分流术 经颈静脉肝内 食管和胃底静脉曲张 出血 肝硬化 肝性脑病 经皮经肝胃冠状静脉栓塞术 再出血率 肝功能 |
| 收稿时间： | 2016-03-09 |
| 修稿时间： | 2016-04-15 |
Comparison of the efficacy transjugular intrahepatic portosystemic shunt and percutaneoustranshepatic variceal embolization for cirrhosis with esophageal gastric varices bleeding |
| |
| YANG Dan,ZHANG Guoliang△,WANG Fengmei△,BIAN Fen,JIA Kefeng. Comparison of the efficacy transjugular intrahepatic portosystemic shunt and percutaneoustranshepatic variceal embolization for cirrhosis with esophageal gastric varices bleeding[J]. Tianjin Medical Journal, 2016, 44(5): 529-534. DOI: 10.11958/20160136 |
| |
| Authors: | YANG Dan ZHANG Guoliang△ WANG Fengmei△ BIAN Fen JIA Kefeng |
| |
| Affiliation: | 1 Department of Gastroenterology, 2 Department of Gastroenterology, the First Central Clinical College, TianjinMedical University, Tianjin 300192, China；3 Department of Gastroenterology and Hepatology,4 Department of Radiology, the Third Central Hospital |
| |
| Abstract: | Abstract：Objective To explore the clinical effect of transjugular intrahepatic portosystemic shunt (TIPS) andpercutaneous transhepatic variceal embolization (PTVE) on the treatment of cirrhosis with esophageal gastric varicesbleeding. Methods The data of 61 patients of liver cirrhosis combined with esophageal gastric varices bleeding whounderwent the interventional treatment were included in the retrospective analysis. Patients were divided into two groups,PTVE treatment group (n=42), and TIPS treatment group (n=19). The success rate of clinical treatment, the rebleeding rate,the alleviation of varicose veins, the incidence of hepatic encephalopathy, survival rate and liver function parameters werecompared between two groups. Results Two groups of surgery were successful. The portal vein pressure decreasedobviously in TIPS group. The rebleeding rate was higher in PTVE group (78.6%) than that in TIPS group (63.2%). The totalalleviation rate of esophageal gastric varices was significantly lower in PTVE group (50.0%) than that in TIPS group (89.5%,P＜0.05). The incidence rates of hepatic encephalopathy were 14.3% and 26.3% for PTVE group and TIPS grouprespectively. The two-year cumulative survival rates of PTVE group and TIPS group were 95.2% and 89.5% respectively,and there was no statistically significant difference between two groups. After surgery, the liver function parameters were notsignificantly different from those determined before the treatment in PTVE group. At 1 month and 3 months after TIPS, theliver functions were declined obviously. At 6 and 12 months after the treatment, the liver functions were not significantlydifferent from those determined before the treatment in PTVE group. Conclusion The surgery of TIPS is safe and idealinterventional treatment for cirrhosis with esophageal gastric varices bleeding, which has the lower rebleeding rate, betteresophageal gastric varices alleviation rate and long term less influence in liver function. |
| |
| Keywords: | portasystemic shunt transjugular intrahepatic esophageal and gastric varices hemorrhage liver cirrhosis hepatic encephalopathy percutaneous transhepatic variceal embolization rebleeding rate liver function |
|
| 点击此处可从《天津医药》浏览原始摘要信息 |
|
点击此处可从《天津医药》下载全文 |
|
